BriaCell Therapeutics (STU:8BT) Shares Buyback Ratio % : -2.99 (As of Apr. 25, 2024)

View and export this data going back to 2016. Start your Free Trial

What is BriaCell Therapeutics Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. BriaCell Therapeutics's current shares buyback ratio was -2.99%.

BriaCell Therapeutics Shares Buyback Ratio % Historical Data

The historical data trend for BriaCell Therapeutics's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BriaCell Therapeutics Shares Buyback Ratio % Chart

BriaCell Therapeutics Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Shares Buyback Ratio %

Get a 7-Day Free Trial

-23.59

-10.30

-2,015.02

-1.63

-2.99

BriaCell Therapeutics Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Shares Buyback Ratio %	Get a 7-Day Free Trial															-	-	-2.99	-	-

BriaCell Therapeutics Shares Buyback Ratio % Calculation

BriaCell Therapeutics's Shares Buyback Ratio for the fiscal year that ended in Jul. 2023 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Jul. 2022 )	-	Shares Outstanding (EOP) (A: Jul. 2023 ))	/	Shares Outstanding (EOP) (A: Jul. 2022 )
	=	(15.518	-	15.9817)	/	15.518
	=	-2.99%

BriaCell Therapeutics's Shares Buyback Ratio for the quarter that ended in Jan. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Oct. 2023 )	-	Shares Outstanding (EOP) (A: Jan. 2024 ))	/	Shares Outstanding (EOP) (A: Oct. 2023 )
	=	(15.9817	-	15.9817)	/	15.9817
	=	0.00%

BriaCell Therapeutics Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of BriaCell Therapeutics's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

BriaCell Therapeutics (STU:8BT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BriaCell Therapeutics Corp (STU:8BT) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

BCTX:USA BCT:Canada

Address

235 - 15th Street, Suite 300, West Vancouver, 3rd Floor, Bellevue Centre, Vancouver, BC, CAN, V7T 2X1

Website

https://www.briacell.com

BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in metastatic breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for the treatment of advance-stage breast cancer by matching the patient's HLA type.

BriaCell Therapeutics (STU:8BT) Headlines

No Headlines